Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Loxo Oncology Inc (NASDAQ:LOXO)

41.74
Delayed Data
As of Feb 17
 +0.36 / +0.87%
Today’s Change
16.50
Today|||52-Week Range
44.95
+29.97%
Year-to-Date
No recent news for Loxo Oncology Inc.

Today’s Trading

Previous close41.38
Today’s open41.24
Day’s range41.16 - 42.49
Volume183,421
Average volume (3 months)212,047
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+30.72%
Earnings growth (this year)-43.21%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.29

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...0.000.00%
RGENRepligen Corp+0.13+0.42%
SGYPSynergy Pharmaceutic...+0.01+0.17%
TXMDTherapeuticsMD Inc-0.15-2.60%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 31, 2017
EPS forecast (this quarter)-$0.83
Annual revenue (last year)$0.00
Annual profit (last year)-$35.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Josh Bilenker
Executive Director-
Business Operations
Sara Slifka
Corporate headquarters
Stamford, Connecticut

Forecasts


Search for Jobs